FDA
approval
· 2025-03-13
FDA Approved: BUCAPSOL — Original Application (PANGEA PHARMACEUTICALS, LLC)
Summary
FDA approved BUCAPSOL, a generic buspirone hydrochloride product, under an Original Abbreviated New Drug Application by PANGEA PHARMACEUTICALS, LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for BUCAPSOL (BUSPIRONE HYDROCHLORIDE)